Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation

Peking University

Status: Enrolling

Conditions: Atrial Fibrillation

Treatments: Other: After radiofrequency ablation of atrial fibrillation

Study type: Observational

Funder types: Other

Identifiers

NCT05638841

2022-653-01

Details and patient eligibility

About

In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.

Enrollment: 300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 1. Age > 18
• 2. ECG or holter electrocardiogram confirmed atrial fibrillation

Exclusion criteria

• 1. Hematological diseases, autoimmune diseases and malignant tumors
• 2. Immobility caused by hemiplegia or severe trauma
• 3. The expected survival time is less than 2 years
• 4. Poor compliance and high risk of expected loss of follow-up
• 5. Disorders of consciousness or Alzheimer's disease

Trial design

300 participants in 1 patient group

atrial fibrillation

Description:

After radiofrequency ablation of patients with atrial fibrillation

Treatment:

Other: After radiofrequency ablation of atrial fibrillation